After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure Industry News July 28, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …
How the Body Battles Against Viruses Like Influenza, RSV and SARS-CoV-2 Infectious Diseases July 27, 2023 …
Senator Murray Applauds Launch of White House Pandemic Preparedness Office Policy + Initiatives July 21, 2023 …
VitriVax Wins DoD Contract to Develop Single-Shot Vaccine for Melioidosis and Glanders Industry News July 19, 2023 …
ASM Responds to Senate Markup of Pandemic and All-Hazards Preparedness and Response Act Policy + Initiatives July 19, 2023 …
New Tool Navigates Legal Landscape for Emerging Infectious Diseases Policy + Initiatives July 19, 2023 …
DARPA Award to Ginkgo Bioworks Aims to Revolutionize Speed of Medical Countermeasure Manufacturing Industry News July 19, 2023 …
NIAID Awards Multiple Contracts for Radiation Medical Countermeasures and Biodosimetry CBRNE July 9, 2023 …
Intelligence Report Says Safety Training at Wuhan Lab Before the Pandemic Appears Routine Biosecurity July 7, 2023 …
Revive Therapeutics Announces Results of Phase 3 Study for Bucillamine in the Treatment of COVID-19 Industry News July 6, 2023 …
Capacity Building: Plans for a Public Health Emergency Operations Center in Armenia Contracts + Grants July 5, 2023 …
UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness Contracts + Grants May 26, 2023 …
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance Antimicrobial Resistance April 26, 2023 …